FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Ingeborg Aaberge

Research Profile

Living Beings

Chemicals & Drugs

Geographic Areas

Norway

Disorders

Concepts & Ideas

Immunization Schedule

Procedures

Co-author Network

Publications

TOP 3
Maria C Magnus; Wenche Nystad; Hein Stigum; Didrik F Vestrheim; Ingeborg S Aaberge; Marianne A Riise Bergsaker; Dominique A Caugant; Siri Eldevik Håberg; Stephanie J London; Per Nafstad
Decline in early childhood respiratory tract infections in the Norwegian mother and child cohort study after introduction of pneumococcal conjugate vaccination.
Didrik F Vestrheim; Martin Steinbakk; Ingeborg S Aaberge; Dominique A Caugant
Postvaccination increase in serotype 19A pneumococcal disease in Norway is driven by expansion of penicillin-susceptible strains of the ST199 complex.
Didrik F Vestrheim; Peter Gaustad; Ingeborg S Aaberge; Dominique A Caugant
Pherotypes of pneumococcal strains co-existing in healthy children.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Ingeborg Aaberge (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2012: Maria C Magnus; Wenche Nystad; Hein Stigum; Didrik F Vestrheim; Ingeborg S Aaberge; Marianne A Riise Bergsaker; Dominique A Caugant; Siri Eldevik Håberg; Stephanie J London; Per Nafstad
Decline in early childhood respiratory tract infections in the Norwegian mother and child cohort study after introduction of pneumococcal conjugate vaccination.
The Pediatric infectious disease journal 2012;31(9):951-5.
2012: Didrik F Vestrheim; Martin Steinbakk; Ingeborg S Aaberge; Dominique A Caugant
Postvaccination increase in serotype 19A pneumococcal disease in Norway is driven by expansion of penicillin-susceptible strains of the ST199 complex.
Clinical and vaccine immunology : CVI 2012;19(3):443-5.
2011: Didrik F Vestrheim; Peter Gaustad; Ingeborg S Aaberge; Dominique A Caugant
Pherotypes of pneumococcal strains co-existing in healthy children.
Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases 2011;11(7):1703-8.
2011: Frank O Pettersen; Per M Sandset; Kjetil Taskén; eirik torheim; Ingeborg S Aaberge; Einar M Aandahl; Anders E A Dahm; Malin Holm; Andreas Lind; Dag Kvale
An exploratory trial of cyclooxygenase type 2 inhibitor in HIV-1 infection: downregulated immune activation and improved T cell-dependent vaccine responses.
Journal of virology 2011;85(13):6557-66.
2010: Karlijn Gijzen; Wai Ming Liu; Ildiko Visontai; Fredrik Oftung; Sylvie van der Werf; Gro Ellen Korsvold; Inge Pronk; Ingeborg S Aaberge; Anna Tütto; Istvan Jankovics; Mate Jankovics; Beth Gentleman; Janet E McElhaney; Ernst C Soethout
Standardization and validation of assays determining cellular immune responses against influenza.
Vaccine 2010;28(19):3416-22.
2010: Didrik F Vestrheim; E Arne Høiby; Marianne R Bergsaker; Karin Rønning; Ingeborg S Aaberge; Dominique A Caugant
Indirect effect of conjugate pneumococcal vaccination in a 2+1 dose schedule.
Vaccine 2010;28(10):2214-21.
2010: Didrik F Vestrheim; E Arne Høiby; Ingeborg S Aaberge; Dominique A Caugant
Impact of a pneumococcal conjugate vaccination program on carriage among children in Norway.
Clinical and vaccine immunology : CVI 2010;17(3):325-34.
2010: Roger Meisal; Ida K G Andreasson; E Arne Høiby; Ingeborg S Aaberge; Terje E Michaelsen; Dominique A Caugant
Streptococcus pyogenes isolates causing severe infections in Norway in 2006 to 2007: emm types, multilocus sequence types, and superantigen profiles.
Journal of clinical microbiology 2010;48(3):842-51.
2009: C Jackson; Diana Lennon; V T K Sotutu; J Yan; J M Stewart; Stewart Reid; Sue Crengle; Philipp Oster; Ellen Ypma; Ingeborg S Aaberge; Kim Mulholland; D R Martin
Phase II meningococcal B vesicle vaccine trial in New Zealand infants.
Archives of disease in childhood 2009;94(10):745-51.
2009: Elisabeth Wedege; T Bergdal; K Bolstad; Dominique A Caugant; J Efskind; H E Heier; A Kanestrøm; Bjørn Heine Strand; Ingeborg S Aaberge
Seroepidemiological study after a long-distance industrial outbreak of legionnaires' disease.
Clinical and vaccine immunology : CVI 2009;16(4):528-34.
2009: Ingeborg S Aaberge
Experience with pneumococcal conjugate vaccine in Norway.
Expert review of vaccines 2009;8(2):159-65.
2008: Janet Martha Blatny; Bjørn Anders P Reif; Gunnar Skogan; Oyvind Andreassen; E Arne Høiby; Eirik Ask; Viggo Waagen; Dag Aanonsen; Ingeborg S Aaberge; Dominique A Caugant
Tracking airborne Legionella and Legionella pneumophila at a biological treatment plant.
Environmental science & technology 2008;42(19):7360-7.
2008: K Borgen; Ingeborg S Aaberge; O Werner-Johansen; K Gjøsund; B Størsrud; S Haugsten; karin nygard; T Krogh; E Arne Høiby; Dominique A Caugant; A Kanestrøm; O Simonsen; Hans Blystad
A cluster of Legionnaires disease linked to an industrial plant in southeast Norway, June-July 2008.
Euro surveillance : bulletin Européen sur les maladies transmissibles = European communicable disease bulletin 2008;13(38):.
2008: Didrik F Vestrheim; E Arne Høiby; Ingeborg S Aaberge; Dominique A Caugant
Phenotypic and genotypic characterization of Streptococcus pneumoniae strains colonizing children attending day-care centers in Norway.
Journal of clinical microbiology 2008;46(8):2508-18.
2008: Didrik F Vestrheim; Oistein Løvoll; Ingeborg S Aaberge; Dominique A Caugant; E Arne Høiby; Hilde Bakke; Marianne R Bergsaker
Effectiveness of a 2+1 dose schedule pneumococcal conjugate vaccination programme on invasive pneumococcal disease among children in Norway.
Vaccine 2008;26(26):3277-81.
2008: Roger Meisal; E Arne Høiby; Ingeborg S Aaberge; Dominique A Caugant
Sequence type and emm type diversity in Streptococcus pyogenes isolates causing invasive disease in Norway between 1988 and 2003.
Journal of clinical microbiology 2008;46(6):2102-5.
2008: Kirsti Vainio; Helvi H Samdal; Gabriel Anestad; Elisabeth Wedege; D H Skutlaberg; K T Bransdal; R Mundal; Ingeborg S Aaberge
Detection of measles- and mumps-specific IgG antibodies in paired serum and oral fluid samples from Norwegian conscripts.
European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology 2008;27(6):461-5.
2008: Philippe Guerin; Lisbeth M Naess; Carole Fogg; Einar Rosenqvist; Loretxu Pinoges; Francis Bajunirwe; Carolyn Nabasumba; Ray Borrow; Leif O Frøholm; Salah Ghabri; Vincent Batwala; Rogers Twesigye; Ingeborg S Aaberge; John-Arne Rottingen; Patrice PIOLA; Dominique A Caugant
Immunogenicity of fractional doses of tetravalent a/c/y/w135 meningococcal polysaccharide vaccine: results from a randomized non-inferiority controlled trial in Uganda.
PLoS neglected tropical diseases 2008;2(12):e342.
2008: Karin Nygård; Øyvind Werner-Johansen; Svein Rønsen; Dominique A Caugant; Øystein Simonsen; Anita Kanestrøm; Eirik Ask; Jetmund Ringstad; Rune Ødegård; Tore Jensen; Truls Krogh; E Arne Høiby; Eivind Ragnhildstveit; Ingeborg S Aaberge; Preben Aavitsland
An outbreak of legionnaires disease caused by long-distance spread from an industrial air scrubber in Sarpsborg, Norway.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2008;46(1):61-9.
2007: Jamie Hosking; Kumanan Rasanathan; Florina Chan Mow; Catherine Jackson; Diana Martin; Jane O'Hallahan; Philipp Oster; Ellen Ypma; Stewart Reid; Ingeborg S Aaberge; Sue Crengle; Joanna Stewart; Diana Lennon
Immunogenicity, reactogenicity, and safety of a P1.7b,4 strain-specific serogroup B meningococcal vaccine given to preteens.
Clinical and vaccine immunology : CVI 2007;14(11):1393-9.
2007: Synne Sandbu; Berit Feiring; Philipp Oster; Oddveig S Helland; Hilde Bakke; Lisbeth M Naess; Audun Aase; Ingeborg S Aaberge; Anne-Cathrine Kristoffersen; Kjersti M Rydland; Sandrine Tilman; Hanne Nøkleby; Einar Rosenqvist
Immunogenicity and safety of a combination of two serogroup B meningococcal outer membrane vesicle vaccines.
Clinical and vaccine immunology : CVI 2007;14(9):1062-9.
2007: Audun Aase; Tove K Herstad; Samuel Merino; Kari Torkildsen Brandsdal; Bjørn Peter Berdal; Erja M Aleksandersen; Ingeborg S Aaberge
Opsonophagocytic activity and other serological indications of Bordetella pertussis infection in military recruits in Norway.
Clinical and vaccine immunology : CVI 2007;14(7):855-62.
2007: Philipp Oster; Jane O'Hallahan; Ingeborg S Aaberge; Sandrine Tilman; Ellen Ypma; Diana Martin
Immunogenicity and safety of a strain-specific MenB OMV vaccine delivered to under 5-year olds in New Zealand.
Vaccine 2007;25(16):3075-9.
2007: Sharon Wong; Diana Lennon; Catherine Jackson; Joanna Stewart; Stewart Reid; Sue Crengle; Sandrine Tilman; Ingeborg S Aaberge; Jane O'Hallahan; Philipp Oster; Kim Mulholland; Diana Martin
New zealand epidemic strain meningococcal B outer membrane vesicle vaccine in children aged 16-24 months.
The Pediatric infectious disease journal 2007;26(4):345-50.
2007: Kirsti Vainio; Helvi H Samdal; Gabriel Anestad; D H Skutlaberg; K T Bransdal; R Mundal; Ingeborg S Aaberge
Seroprevalence of measles among Norwegian military conscripts in 2004.
European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology 2007;26(3):217-20.
2007: Maren K R Sogstad; Pia Littauer; Ingeborg S Aaberge; Dominique A Caugant; Arne Høiby
Rapid spread in Norway of an erythromycin-resistant pneumococcal clone, despite low usage of macrolides.
Microbial drug resistance (Larchmont, N.Y.) 2007;13(1):29-36.
2006: Dominique A Caugant; Carole Fogg; Francis Bajunirwe; Patrice PIOLA; Rogers Twesigye; Fred Mutebi; L Oddvar Frøholm; Einar Rosenqvist; Vincent Batwala; Ingeborg S Aaberge; John-Arne Rottingen; Philippe Guerin
Pharyngeal carriage of Neisseria meningitidis in 2-19-year-old individuals in Uganda.
Transactions of the Royal Society of Tropical Medicine and Hygiene 2006;100(12):1159-63.
2006: Maren K R Sogstad; Ingeborg S Aaberge; J O Sørdal; E Arne Høiby; L Oddvar Frøholm; A R Alme; Dominique A Caugant
Carriage of Streptococcus pneumoniae in healthy Norwegian children attending day-care centres.
European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology 2006;25(8):510-4.
2006: Berit Feiring; Jan Fuglesang; Philipp Oster; Lisbeth M Naess; Oddveig S Helland; Sandrine Tilman; Einar Rosenqvist; Marianne A Riise Bergsaker; Hanne Nøkleby; Ingeborg S Aaberge
Persisting immune responses indicating long-term protection after booster dose with meningococcal group B outer membrane vesicle vaccine.
Clinical and vaccine immunology : CVI 2006;13(7):790-6.
2006: Ray Borrow; G M Carlone; Nancy E Rosenstein; M Blake; Ian M Feavers; Diana Martin; W Zollinger; J Robbins; Ingeborg S Aaberge; Dan M Granoff; Elizabeth Miller; Bonnie B Plikaytis; L van Alphen; Jan Poolman; R Rappuoli; Lisa Danzig; J Hackell; B Danve; M Caulfield; S Lambert; David S Stephens
Neisseria meningitidis group B correlates of protection and assay standardization--international meeting report Emory University, Atlanta, Georgia, United States, 16-17 March 2005.
Vaccine 2006;24(24):5093-107.
2006: V Thornton; Diana Lennon; Kumanan Rasanathan; Jane O'Hallahan; Philipp Oster; Joanna Stewart; Sandrine Tilman; Ingeborg S Aaberge; Berit Feiring; H Nokleby; Einar Rosenqvist; K White; Stewart Reid; Kim Mulholland; M J Wakefield; Diana Martin
Safety and immunogenicity of New Zealand strain meningococcal serogroup B OMV vaccine in healthy adults: beginning of epidemic control.
Vaccine 2006;24(9):1395-400.
2005: Ray Borrow; Ingeborg S Aaberge; George F Santos; T Lynn Eudey; Philipp Oster; Anne Glennie; Jamie Findlow; E Arne Høiby; Einar Rosenqvist; Paul Balmer; Diana Martin
Interlaboratory standardization of the measurement of serum bactericidal activity by using human complement against meningococcal serogroup b, strain 44/76-SL, before and after vaccination with the Norwegian MenBvac outer membrane vesicle vaccine.
Clinical and diagnostic laboratory immunology 2005;12(8):970-6.
2005: Ingeborg S Aaberge; Philipp Oster; Oddveig S Helland; Anne-Cathrine Kristoffersen; Ellen Ypma; E Arne Høiby; Berit Feiring; Hanne Nøkleby
Combined administration of meningococcal serogroup B outer membrane vesicle vaccine and conjugated serogroup C vaccine indicated for prevention of meningococcal disease is safe and immunogenic.
Clinical and diagnostic laboratory immunology 2005;12(5):599-605.
2005: Johan Holst; Berit Feiring; Lisbeth M Naess; Gunnstein Norheim; Paul Kristiansen; E Arne Høiby; Klaus Bryn; Philipp Oster; paolo costantino; Muhamed-Kheir Taha; Jean-Michel Alonso; Dominique A Caugant; Elisabeth Wedege; Ingeborg S Aaberge; Rino Rappuoli; Einar Rosenqvist
The concept of "tailor-made", protein-based, outer membrane vesicle vaccines against meningococcal disease.
Vaccine 2005;23(17-18):2202-5.
2005: Sebastian Hoffmann; Anja Peterbauer; Stefanie Schindler; Stefan Fennrich; Stephen Poole; Yogesh Mistry; Thomas Montag-Lessing; Ingo Spreitzer; Bettina Löschner; Mirjam van Aalderen; Rogier Bos; Martin Gommer; Ria Nibbeling; Gabriele Werner-Felmayer; Petra Loitzl; Thomas W Jungi; Marija Brcic; Peter Brügger; Esther Frey; Gerard Bowe; Juan Casado; Sandra Coecke; Jan de Lange; Bente Mogster; Lisbeth M Naess; Ingeborg S Aaberge; Albrecht Wendel; Thomas Hartung
International validation of novel pyrogen tests based on human monocytoid cells.
Journal of immunological methods 2005;298(1-2):161-73.
2004: Kerry Sexton; Diana Lennon; Philipp Oster; Ingeborg S Aaberge; Diana Martin; Stewart Reid; Sharon Wong; Jane O'Hallahan
Proceedings of the Meningococcal Vaccine Strategy World Health Organization satellite meeting, 10 March 2004, Auckland, New Zealand.
The New Zealand medical journal 2004;117(1200):1 p preceding U1027.
2004: Hilde Bakke; Torhild N Setek; Phuong N Huynh; Inger Lise Haugen; E Arne Høiby; Johan Holst; Ingeborg S Aaberge; Bjørn Haneberg
Immunisation schedules for non-replicating nasal vaccines can be made simple by allowing time for development of immunological memory.
Vaccine 2004;22(17-18):2278-84.
2003: Tor Strand; Ingeborg S Aaberge; Amund Maage; Elling Ulvestad; Halvor Sommerfelt
The immune response to pneumococcal polysaccharide vaccine in zinc-depleted mice.
Scandinavian journal of immunology 2003;58(1):76-80.
2003: Johan Holst; Berit Feiring; J E Fuglesang; E Arne Høiby; Hanne Nøkleby; Ingeborg S Aaberge; Einar Rosenqvist
Serum bactericidal activity correlates with the vaccine efficacy of outer membrane vesicle vaccines against Neisseria meningitidis serogroup B disease.
Vaccine 2003;21(7-8):734-7.
2002: Libuse Janakova; Hilde Bakke; Inger Lise Haugen; Aud Katrine Herland Berstad; E Arne Høiby; Ingeborg S Aaberge; Bjørn Haneberg
Influence of intravenous anesthesia on mucosal and systemic antibody responses to nasal vaccines.
Infection and immunity 2002;70(10):5479-84.
2002: Dag Kvale; Ingeborg S Aaberge; Stig S Frøland
Predictive value of immunologic parameters and HIV RNA in relation to humoral pneumococcal polysaccharide vaccine responses in patients with HIV infection.
European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology 2002;21(9):688-90.
2002: Tone Nordøy; Ingeborg S Aaberge; Anne Husebekk; Helvi H Samdal; Svein Steinert; Hasse Melby; Arne Kolstad
Cancer patients undergoing chemotherapy show adequate serological response to vaccinations against influenza virus and Streptococcus pneumoniae.
Medical oncology (Northwood, London, England) 2002;19(2):71-8.
2001: Tone Nordøy; Anne Husebekk; Ingeborg S Aaberge; Pål A Jenum; Helvi H Samdal; L B Flugsrud; Anne-Cathrine Kristoffersen; Harald Holte; Stein Kvaløy; Arne Kolstad
Humoral immunity to viral and bacterial antigens in lymphoma patients 4-10 years after high-dose therapy with ABMT. Serological responses to revaccinations according to EBMT guidelines.
Bone marrow transplantation 2001;28(7):681-7.
2001: Hilde Bakke; K Lie; Inger Lise Haugen; Gro Ellen Korsvold; E Arne Høiby; Lisbeth M Naess; Johan Holst; Ingeborg S Aaberge; Fredrik Oftung; Bjørn Haneberg
Meningococcal outer membrane vesicle vaccine given intranasally can induce immunological memory and booster responses without evidence of tolerance.
Infection and immunity 2001;69(8):5010-5.
2001: Tone Nordøy; Arne Kolstad; Melissa Tuck; Ingeborg S Aaberge; Anne Husebekk; Mark S Kaminski
Radioimmunotherapy with iodine-131 tositumomab in patients with low-grade non-Hodgkin's B-cell lymphoma does not induce loss of acquired humoral immunity against common antigens.
Clinical immunology (Orlando, Fla.) 2001;100(1):40-8.
2001: Thomas Hartung; Ingeborg S Aaberge; S Berthold; G Carlin; E Charton; Sandra Coecke; Stefan Fennrich; M Fischer; M Gommer; Marlies Halder; K Haslov; M Jahnke; Thomas Montag-Lessing; Stephen Poole; Leonard M Schechtman; Albrecht Wendel; Gabriele Werner-Felmayer
Novel pyrogen tests based on the human fever reaction. The report and recommendations of ECVAM Workshop 43. European Centre for the Validation of Alternative Methods. European Centre for the Validation of Alternative Methods.
Alternatives to laboratory animals : ATLA 2001;29(2):99-123.
2000: Geir Hetland; Anne Berit Samuelsen; Martinus Løvik; Berit Smestad Paulsen; Ingeborg S Aaberge; Else-Carin Groeng; Terje E Michaelsen
Protective effect of Plantago major L. Pectin polysaccharide against systemic Streptococcus pneumoniae infection in mice.
Scandinavian journal of immunology 2000;52(4):348-55.
2000: Geir Hetland; N Ohno; Ingeborg S Aaberge; M Lovik
Protective effect of beta-glucan against systemic Streptococcus pneumoniae infection in mice.
FEMS immunology and medical microbiology 2000;27(2):111-6.
1999: B K Hvalbye; Ingeborg S Aaberge; Martinus Løvik; Bjørn Haneberg
Intranasal immunization with heat-inactivated Streptococcus pneumoniae protects mice against systemic pneumococcal infection.
Infection and immunity 1999;67(9):4320-5.
1999: AK Lehmann; A Halstensen; Ingeborg S Aaberge; Johan Holst; Terje E Michaelsen; S Sornes; Wetzler Lee; Hilde-Kari Guttormsen
Human opsonins induced during meningococcal disease recognize outer membrane proteins PorA and PorB.
Infection and immunity 1999;67(5):2552-60.
1999: Ingeborg S Aaberge
Pneumococcal vaccine in the elderly: the Norwegian experience.
Drugs & aging 1999;15 Suppl 1():37-41.
1999: TE Steinsvik; Ingeborg S Aaberge; Per Ivar Gaarder; Martinus Løvik
Interleukin-13 and human immunoglobulin E production in severe combined immunodeficiency mice transplanted with human peripheral blood lymphocytes.
Scandinavian journal of immunology 1999;49(1):67-72.
1998: TE Steinsvik; Heidi Ormstad; Per Ivar Gaarder; Ingeborg S Aaberge; U Bjønness; Martinus Løvik
Human IgE production in hu-PBL-SCID mice injected with birch pollen and diesel exhaust particles.
Toxicology 1998;128(3):219-30.
1997: TE Steinsvik; Ingeborg S Aaberge; Per Ivar Gaarder; U Bjønness; Martinus Løvik
Total and birch pollen-specific human IgE in mice with severe combined immunodeficiency transplanted with human peripheral blood lymphocytes: donor dependence, seasonal variation and in vivo half-life.
International archives of allergy and immunology 1997;112(2):175-83.
1996: Ingeborg S Aaberge; B Hvalbye; Martinus Løvik
Enhancement of Streptococcus pneumoniae serotype 6B infection in mice after passive immunization with human serum.
Microbial pathogenesis 1996;21(2):125-37.
1996: Ingeborg S Aaberge; T E Steinsvik; E C Groeng; R B Leikvold; Martinus Løvik
Human antibody response to a pneumococcal vaccine in SCID-PBL-hu mice and simultaneously vaccinated human cell donors.
Clinical and experimental immunology 1996;105(1):12-7.
1996: Ingeborg S Aaberge; Martinus Løvik
The antibody response after immunization with pneumococcal polysaccharide vaccine in splenectomized mice: the effect of re-immunization with pneumococcal antigens.
APMIS : acta pathologica, microbiologica, et immunologica Scandinavica 1996;104(4):307-17.
1996: Martinus Løvik; H R Johansen; Per Ivar Gaarder; Georg Becher; Ingeborg S Aaberge; W Gdynia; Jan Alexander
Halogenated organic compounds and the human immune system: preliminary report on a study in hobby fishermen.
Archives of toxicology. Supplement. = Archiv für Toxikologie. Supplement 1996;18():15-20.
1995: Ingeborg S Aaberge; Martinus Løvik
The antibody response to secondary immunization with pneumococcal polysaccharides in mice.
Scandinavian journal of immunology 1995;42(6):617-25.
1995: T E Steinsvik; Per Ivar Gaarder; Ingeborg S Aaberge
Engraftment and humoral immunity in SCID and RAG-2-deficient mice transplanted with human peripheral blood lymphocytes.
Scandinavian journal of immunology 1995;42(6):607-16.
1995: Ingeborg S Aaberge; J Eng; G Lermark; Martinus Løvik
Virulence of Streptococcus pneumoniae in mice: a standardized method for preparation and frozen storage of the experimental bacterial inoculum.
Microbial pathogenesis 1995;18(2):141-52.
1994: TE Steinsvik; Ingeborg S Aaberge; D Belsnes; Per Ivar Gaarder; Martinus Løvik
Specific human IgE response after immunization with birch pollen in scid mice transplanted with human peripheral blood mononuclear cells-A model for human allergy?
Toxicology in vitro : an international journal published in association with BIBRA 1994;8(5):1049-51.
1993: Ingeborg S Aaberge; R J North; E C Groeng; Martinus Løvik
Antibody response to pneumococcal polysaccharide vaccine in young, adult and old mice.
Scandinavian journal of immunology 1993;38(1):17-30.
1992: Ingeborg S Aaberge; Terje E Michaelsen; A K Rolstad; E C Groeng; P Solberg; Martinus Løvik
SCID-Hu mice immunized with a pneumococcal vaccine produce specific human antibodies and show increased resistance to infection.
Infection and immunity 1992;60(10):4146-53.
1992: Jan Kolberg; Ingeborg S Aaberge; Erik Jantzen; Martinus Løvik; G Lermark; T Steen
Murine monoclonal antibodies against pneumococcal capsular polysaccharide types 4, 8, 22F and 19A/19F.
APMIS : acta pathologica, microbiologica, et immunologica Scandinavica 1992;100(1):91-4.
1990: Ingeborg S Aaberge; Terje E Michaelsen; H E Heier
IgG subclass antibody responses to pneumococcal polysaccharide vaccine in splenectomized, otherwise normal, individuals.
Scandinavian journal of immunology 1990;31(6):711-6.
1987: Ingeborg S Aaberge; H E Heier; E C Groeng
IgA response to pneumococcal polysaccharide vaccine in individuals splenectomized because of trauma.
Acta pathologica, microbiologica, et immunologica Scandinavica. Section C, Immunology 1987;95(5):221-3.
1986: Ingeborg S Aaberge; Per Ivar Gaarder
Autoantibodies in individuals splenectomized because of trauma.
Scandinavian journal of haematology 1986;37(4):296-300.
1984: Ingeborg S Aaberge; H E Heier
Long-term effect of pneumococcal polysaccharide vaccination on serum IgM and IgG antibody levels in individuals splenectomized for trauma.
Acta pathologica, microbiologica, et immunologica Scandinavica. Section C, Immunology 1984;92(6):363-9.
1984: Ingeborg S Aaberge; H E Heier; E Hem; K E Giercksky; E C Groeng
IgM and IgG response to pneumococcal polysaccharide vaccine in normal individuals and individuals splenectomized due to trauma.
Acta pathologica, microbiologica, et immunologica Scandinavica. Section C, Immunology 1984;92(1):11-6.